AstraZeneca PLC (AZN)

55.81 -0.93  -1.64% NYSE Aug 13, 13:28 USD

AstraZeneca Total Assets (Quarterly):

59.93B for June 30, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Total Assets (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Total Assets (Quarterly) Data

View and export this data going back to 1993. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2020 59.93B
March 31, 2020 57.21B
Dec. 31, 2019 61.38B
Sept. 30, 2019 58.91B
June 30, 2019 61.89B
March 31, 2019 61.06B
Dec. 31, 2018 60.65B
Sept. 30, 2018 61.44B
June 30, 2018 61.34B
March 31, 2018 63.28B
Dec. 31, 2017 63.35B
Sept. 30, 2017 64.59B
June 30, 2017 65.12B
March 31, 2017 60.96B
Dec. 31, 2016 62.53B
Sept. 30, 2016 63.22B
June 30, 2016 64.42B
March 31, 2016 64.32B
Dec. 31, 2015 60.06B
Sept. 30, 2015 54.12B
June 30, 2015 55.17B
March 31, 2015 53.70B
Dec. 31, 2014 58.60B
Sept. 30, 2014 56.16B
June 30, 2014 58.54B
   
March 31, 2014 59.39B
Dec. 31, 2013 55.90B
Sept. 30, 2013 54.12B
June 30, 2013 53.99B
March 31, 2013 52.33B
Dec. 31, 2012 53.53B
Sept. 30, 2012 52.45B
June 30, 2012 51.39B
March 31, 2012 50.76B
Dec. 31, 2011 52.83B
Sept. 30, 2011 52.58B
June 30, 2011 53.41B
March 31, 2011 54.53B
Dec. 31, 2010 56.13B
Sept. 30, 2010 56.39B
June 30, 2010 54.65B
March 31, 2010 54.08B
Dec. 31, 2009 54.92B
Sept. 30, 2009 51.90B
June 30, 2009 50.20B
March 31, 2009 46.52B
Dec. 31, 2008 46.95B
Sept. 30, 2008 48.20B
June 30, 2008 50.20B
March 31, 2008 48.46B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Benchmarks

Benchmarks
GlaxoSmithKline PLC 104.18B
Emergent BioSolutions Inc 2.466B
Gilead Sciences Inc 55.93B

Total Assets (Quarterly) Range, Past 5 Years

Minimum 54.12B Sep 2015
Maximum 65.12B Jun 2017
Average 61.49B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.